Ole Dragsbæk Madsen

Ole Dragsbæk Madsen

Auto-generated profile, based on publicly available information

Ole Dragsbæk Madsen

Hagedorn Research Institute

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2008 in Journal of Histochemistry & Cytochemistry
Verified
Journal Article
Open access
JHJacob Hald
Jacob Hald
ASAnne Ejrnæs Sprinkel
Anne Ejrnæs Sprinkel
MRMichael Ray
Michael Ray
PSPalle Serup
Palle Serup
CWChris Wright
Chris Wright
OMOle D. Madsen
Ole D. Madsen
Ptf1a and Pdx1 are critical transcription factors of early pancreatic development, as shown by loss of function studies where lack of each gene alone causes almost complete pancreas agenesis. Ptf1a is particularly interesting because it is linked to a recently reported signature gene expression profile associated with the multipotent condition. Few useful antibody reagents have been available for consistent and reliable immunohistochemical visualization of Ptf1a protein expression in the early developing pancreas in which the level of production of this critical regulator seems to be very low. We describe a novel rabbit antibody raised against the c-terminal portion of the mouse Ptf1a protein and report immunodetection, for the first time, as early as embryonic day (e) 8.5–e8.75 in the dorsal and ventral buds of the mouse pancreas as well as in the neural tube at e10.0. Detailed confocal analysis identifies an abundant triple-positive (Ptf1a+/Nkx6.1+/Pdx1+) putative early multipotent pancreatic progenitor cell that marks the e9.5 dorsal pancreas and e10.5 ventral pancreas. Furthermore, expression patterns of Nkx6.1 vs Ptf1a subsequently segregate during branching morphogenesis (trunk vs tip), ending up marking two distinct cell populations of progenitors at e12.5. From e15.5 (mouse) and in adult pancreas (mouse, rat, and human), the Ptf1a antibody marks only acinar cell nuclei, as expected for its subsequent role in committing/maintaining cells in this differentiated state. In summary, this antibody is a novel tool to further characterize important early steps of pancreas differentiation. This manuscript contains online supplemental material at http://www.jhc.org . Please visit this article online to view these materials.

23 September 2011 in Diabetologia
Verified
Journal Article
Closed access
PDF file
JHJ. Hald
J. Hald
TGT. Galbo
T. Galbo
CRC. Rescan
C. Rescan
LRL. Radzikowski
L. Radzikowski
ASA. E. Sprinkel
A. E. Sprinkel
OMO. D. Madsen
O. D. Madsen

1 November 2005 in APMIS
Verified
Journal Article
Open access
PDF file
OMOle Dragsbæk Madsen
Ole Dragsbæk Madsen
Diabetes mellitus types 1 and 2 are characterized by absolute versus relative lack of insulin‐producing β cells, respectively. Reconstitution of a functional β‐cell mass by cell therapy – using organ donor islets of Langerhans – has been demonstrated to restore euglycaemia in the absence of insulin treatment. This remarkable achievement has stimulated the search for appropriate stem cell sources from which adequate expansion and maturation of therapeutic β cells can be achieved. This recent activity is reviewed and presented with particular focus on directed differentiation from pluripotent embryonic stem cells (versus other stem/progenitor cell sources) based on knowledge from pancreatic β‐cell development and the parallel approach to controlling endogenous β‐cell neogenesis.

8 August 2011 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
PJP. B. Jensen
P. B. Jensen
PLP. J. Larsen
P. J. Larsen
CKC. Karlsen
C. Karlsen
HJH. I. Jensen
H. I. Jensen
Jens HolstJens Holst
Jens Holst
OMO. D. Madsen
O. D. Madsen

1 January 2011
Verified
Book Chapter
Closed access
PDF file
MHMattias Hansson
Mattias Hansson
OMOle Dragsbæk Madsen
Ole Dragsbæk Madsen

20 January 2010
Verified
Book Chapter
Closed access
PDF file
RHR. Scott Heller
R. Scott Heller
OMOle D. Madsen
Ole D. Madsen